Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4Pancreatic Intraductal Neoplasms 2

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × tocotrienol, delta × Clear all
NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
4 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT01450046 2016-07-07

Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01446952 2016-04-11

Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00985777 2016-03-01

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
26 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡